Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists.

Papouin T, Ladépêche L, Ruel J, Sacchi S, Labasque M, Hanini M, et al.. Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell. 2012;150(3):633-46. DOI: 10.1016/j.cell.2012.06.029. PubMed PMID: 22863013.

D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices.

Shleper M, Kartvelishvily E, Wolosker H. D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices. J Neurosci. 2005;25(41):9413-7. DOI: 10.1523/JNEUROSCI.3190-05.2005. PubMed PMID: 16221850.

Glycine binding primes NMDA receptor internalization.

Nong Y, Huang Y-Q, Ju W, Kalia LV, Ahmadian G, Wang YT, et al. Glycine binding primes NMDA receptor internalization. Nature. 2003;422(6929):302-7. DOI: 10.1038/nature01497. PubMed PMID: 12646920.

Nicotine exposure in vivo induces long-lasting enhancement of NMDA receptor-mediated currents in the hippocampus.

Yamazaki Y, Jia Y, Niu R, Sumikawa K. Nicotine exposure in vivo induces long-lasting enhancement of NMDA receptor-mediated currents in the hippocampus. Eur J Neurosci. 2006;23(7):1819-28. DOI: 10.1111/j.1460-9568.2006.04714.x. PubMed PMID: 16623839.

The NR1 N-methyl-D-aspartate subunit and brain-derived neurotrophic factor in temporal lobe epilepsy hippocampus: a comparison of patients with and without coexisting psychiatric symptoms.

Toro CT, Hallak JE, Dunham JS, Leite JP, Sakamoto AC, Guarnieri R, et al. The NR1 N-methyl-D-aspartate subunit and brain-derived neurotrophic factor in temporal lobe epilepsy hippocampus: a comparison of patients with and without coexisting psychiatric symptoms. Epilepsia. 2007;48(12):2352-6. DOI: 10.1111/j.1528-1167.2007.01194.x. PubMed PMID: 17919302.

BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.

Harrisberger F, Smieskova R, Schmidt A, Lenz C, Walter A, Wittfeld K, et al. BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2015;55:107-18. DOI: 10.1016/j.neubiorev.2015.04.017. PubMed PMID: 25956254.

Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.

Zhang XY, Chen DC, Xiu MH, Haile CN, Luo X, Xu K, et al. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum Genet. 2012;131(7):1187-95. DOI: 10.1007/s00439-012-1150-x. PubMed PMID: 22362486; PubMed Central PMCID: PMC3671849.

Neurotrophic factors and the pathophysiology of schizophrenic psychoses.

Durany N, Thome J. Neurotrophic factors and the pathophysiology of schizophrenic psychoses. European Psychiatry. 2004;19(6):326-37. DOI: 10.1016/j.eurpsy.2004.06.020. PubMed PMID: 15363470.

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses.

Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 2001;410(6828):588-92. DOI: 10.1038/35069076. PubMed PMID: 11279497.

Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids.

Alger BE. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol. 2002;68(4):247-86. PubMed PMID: 12498988.